In an article published in Current Drug Metabolism 2014 Jan;15(1):14-22, it was demonstrated the Green Tea (epigallocatechin-3-gallate (EGCG)) has cancer prevention properties in various cancers including prostate cancer, bladder cancer, breast, intestinal cancer, colon cancer, gastric cancer, lung cancer, oral cancer and skin cancer. (See the abstract below) Green tea extract is available at Medical Detective!
Douglas C. Hall, M.D.
Curr Drug Metab. 2014 Jan;15(1):14-22.
Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers.
- 1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. email@example.com.
Green tea is one of the most popular beverages around the world. For several decades, numerous epidemiological, preclinical and clinical studies have demonstrated that green tea polyphenols (GTPs), especially epigallocatechin-3-gallate (EGCG) have cancer-preventing effects on various cancers. In this review, we present inhibition of carcinogenesis in different animal models by GTPs or EGCG, including prostate cancer, bladder cancer, breast, intestinal cancer, colon cancer, gastric cancer, lung cancer, oral cancer and skin cancer. In vitro studies showed that GTPs/EGCG potently induces apoptosis, cell cycle arrest and suppresses metastasis in tumor cells but not in their normal cell counterparts. The molecular mechanisms of these activities are discussed in detail to elucidate GTPs/EGCG downstream carcinogenesis signaling pathways and their values of perspective of chemo-prevention and treatment for cancers. PMID: 24329111